In this episode of 'How to Scale a Business,' we delve into the groundbreaking work of Salve Therapeutics, a visionary company at the forefront of revolutionizing gene therapy and drug development. Join us as we explore their mission to expand the frontiers of medicine and bring hope to patients with intractable and incurable genetic diseases.

Discover how Salve Therapeutics is creating VirCAD© (Virus Computer-Aided Design), a cutting-edge platform powered by high-performance computing, accessible in the cloud, and equipped with AI/ML capabilities. This bioCAD platform is poised to change the landscape of cell and gene therapies, vaccines, oncolytics, antibiotics, and more by designing and testing new viral drugs with unmatched precision, efficiency, and customizability.

Tune in to gain exclusive insights into the future of precision medicine and learn how Salve Therapeutics is spearheading innovation to provide targeted solutions for genetic disorders, offering new hope to countless patients around the world.